Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis-an EORTC STBSG and ROG study (EORTC 62991-22998)

Author(s):
Keus, R.B.; Nout, R.A.; Blay, J.Y.; Jong, J.M. de; Hennig, I.; Saran, F.; Hartmann, J.T.; Sunyach, M.P.; Gwyther, S.J.; Ouali, M.; Kirkpatrick, A.; Poortmans, P.M.; Hogendoorn, P.C.W. (0000-0002-1513-8104); Graaf, W.T.A. van der
Published
2013
Publication type
Article / Letter to editor
desmoid-type fibromatosisaggressive fibromatosisdesmoid tumorsradiotherapysoft tissue tumors
Date issued
2013-10-31
Language
English
Is part of
Annals of Oncology (2013), Vol. 24, no. 10, p. 2672-2676
hdl
1887/108318
doi
10.1093/annonc/mdt254